Clinical Trials

tgAAC-94 in rheumatoid arthritis

A phase 1/2 clinical study of intra-articular administration of a recombinant adeno-associated vector containing a TNF-antagonist gene in inflammatory arthritis

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here